Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1414)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$551.76
Total Value
$198.64K
Shares Held After
40,913
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$551.03
Total Value
$552.68K
Shares Held After
41,273
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,357
Price
$550.06
Total Value
$746.43K
Shares Held After
42,276
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,300
Price
$548.74
Total Value
$713.36K
Shares Held After
43,633
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,086
Price
$548.01
Total Value
$1.14M
Shares Held After
44,933
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,234
Price
$547.03
Total Value
$1.22M
Shares Held After
47,019
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$545.93
Total Value
$414.90K
Shares Held After
49,253
% of Holdings
1.5%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
5,000
Price
$70.00
Total Value
$350.00K
Shares Held After
0
% of Holdings
100.0%
Lite Strategy, Inc. (LITS)
Flynn James P — Director
Shares
25,000
Price
$0.86
Total Value
$21.39K
Shares Held After
125,000
% of Holdings
20.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
30,000
Price
$21.42
Total Value
$642.68K
Shares Held After
59,992
% of Holdings
33.3%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
11,223
% of Holdings
3.4%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
30,547
% of Holdings
1.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
114
Price
$14.98
Total Value
$1.71K
Shares Held After
169,556
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,979
Price
$14.60
Total Value
$101.89K
Shares Held After
169,670
% of Holdings
4.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
666
Price
$14.98
Total Value
$9.98K
Shares Held After
793,328
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
40,679
Price
$14.60
Total Value
$593.91K
Shares Held After
793,994
% of Holdings
4.9%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
37,167
Price
$70.00
Total Value
$2.60M
Shares Held After
8,383
% of Holdings
81.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
6,431
Price
$29.66
Total Value
$190.74K
Shares Held After
890,809
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,696
Price
$8.16
Total Value
$46.47K
Shares Held After
187,432
% of Holdings
2.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
30,774
Price
$21.13
Total Value
$650.25K
Shares Held After
1,106,036
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
39,131
Price
$21.13
Total Value
$826.84K
Shares Held After
1,510,157
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
77,855
Price
$21.13
Total Value
$1.65M
Shares Held After
4,805,639
% of Holdings
1.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
173
Price
$99.98
Total Value
$17.30K
Shares Held After
613,589
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,235
Price
$99.98
Total Value
$123.48K
Shares Held After
3,461,521
% of Holdings
0.0%
Aditxt, Inc. (ADTX)
Takeover Time 2026 LLC — 10% Owner
Shares
3,420,439
Price
$0.02
Total Value
$68.41K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
320
Price
$275.10
Total Value
$88.03K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,290
Price
$274.12
Total Value
$353.61K
Shares Held After
320
% of Holdings
80.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,800
Price
$273.30
Total Value
$491.95K
Shares Held After
1,610
% of Holdings
52.8%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,068
Price
$276.74
Total Value
$295.55K
Shares Held After
0
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
117,592
Price
$54.47
Total Value
$6.41M
Shares Held After
559,399
% of Holdings
17.4%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
32,408
Price
$54.11
Total Value
$1.75M
Shares Held After
676,991
% of Holdings
4.6%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,292
Price
$276.26
Total Value
$356.93K
Shares Held After
0
% of Holdings
100.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,450
Price
$18.00
Total Value
$26.10K
Shares Held After
51,776
% of Holdings
2.7%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$117.94
Total Value
$1.06M
Shares Held After
7,825
% of Holdings
53.5%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
9,810
Price
$12.00
Total Value
$117.72K
Shares Held After
8,617
% of Holdings
53.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,175
Price
$20.00
Total Value
$43.50K
Shares Held After
62,371
% of Holdings
3.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
3,000
Price
$20.00
Total Value
$60.00K
Shares Held After
67,845
% of Holdings
4.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
11,845
Price
$20.22
Total Value
$239.52K
Shares Held After
59,992
% of Holdings
16.5%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
7,557
Price
$3.14
Total Value
$23.73K
Shares Held After
0
% of Holdings
100.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,500
Price
$10.00
Total Value
$25.00K
Shares Held After
130,180
% of Holdings
1.9%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,000
Price
$9.47
Total Value
$142.05K
Shares Held After
132,680
% of Holdings
10.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,117
Price
$0.90
Total Value
$3.70K
Shares Held After
1,724,349
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
15,112
Price
$0.90
Total Value
$13.59K
Shares Held After
1,140,434
% of Holdings
1.3%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,311
Price
$0.90
Total Value
$10.17K
Shares Held After
3,669,802
% of Holdings
0.3%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
7,794
Price
$0.90
Total Value
$7.01K
Shares Held After
1,182,429
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
75,000
Price
$0.04
Total Value
$3.38K
Shares Held After
93,769,319
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
17,426
Price
$14.25
Total Value
$248.32K
Shares Held After
176,649
% of Holdings
9.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
101,579
Price
$14.25
Total Value
$1.45M
Shares Held After
834,673
% of Holdings
10.8%
Nuvation Bio Inc. (NUVB)
Markel Stacy — CHIEF PEOPLE OFFICER
Shares
125,000
Price
$6.03
Total Value
$753.19K
Shares Held After
32,591
% of Holdings
79.3%
Showing 401–450 of 1414 transactions (page 9 of 29)